Abstract | BACKGROUND: METHODS: A retrospective analysis of 88 consecutive patients with symptomatic BPH was carried out, who underwent either 120-W ThuVEP or HoLEP nonrandomly. Patient demographics and peri-operative and 12-month follow-up data were analyzed with the International Prostate Symptom Score (IPSS), quality of life (QoL) score, maximum flow rate (Qmax), postvoid residual urine volume (PVR), and rates of peri-operative and late complications. RESULTS: The patients in each group showed no significant difference in preoperative parameters. Compared with the HoLEP group, patients in the 120-W ThuVEP group required significantly shorter time for laser enucleation (58.3 ± 12.8 min vs. 70.5 ± 22.3 min, P = 0.003), and resulted in a significant superiority in laser efficiency (resected prostate weight/ laser enucleation time) for 120-W Tm: YAG laser compared to holmium:YAG laser (0.69 ± 0.18 vs. 0.61 ± 0.19, P = 0.048). During 1, 6, and 12 months of follow-ups, the procedures did not demonstrate a significant difference in IPSS, QoL score, Qmax, or PVR (P > 0.05). Mean peri-operative decrease of hemoglobin in the HoLEP group was similar to the ThuVEP group (17.1 ± 12.0 g/L vs. 15.2 ± 10.1 g/L, P = 0.415). Early and late incidences of complications were low and did not differ significantly between the two groups of 120-W ThuVEP and HoLEP patients (P > 0.05). CONCLUSIONS: 120-W ThuVEP and HoLEP are potent, safe and efficient modalities of minimally invasive surgeries for patients with LUTS due to BPH. Compared with HoLEP, 120-W ThuVEP offers advantages of reduction of laser enucleation time and improvement of laser efficiency.
|
Authors | Kai Hong, Yu-Qing Liu, Jian Lu, Chun-Lei Xiao, Yi Huang, Lu-Lin Ma |
Journal | Chinese medical journal
(Chin Med J (Engl))
Vol. 128
Issue 7
Pg. 884-9
(Apr 05 2015)
ISSN: 2542-5641 [Electronic] China |
PMID | 25836607
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- yttrium-aluminum-garnet
- Yttrium
- Thulium
- Aluminum
|
Topics |
- Aged
- Aluminum
(therapeutic use)
- Humans
- Laser Therapy
- Male
- Middle Aged
- Prostate
(surgery)
- Prostatic Hyperplasia
(surgery)
- Quality of Life
- Retrospective Studies
- Thulium
(therapeutic use)
- Treatment Outcome
- Yttrium
(therapeutic use)
|